TABLE 5

PTIP values and cellular uptake parameters of selected transporter/inhibitor pairs

For comparability across PTIP-positive and PTIP-negative transporter/inhibitor combinations, “NSB block −” PTIP values are shown in each case. When determined in the presence of a specific and potent inhibitor, Kp reflects passive equilibration. Kp,uu values >1 indicate active accumulation. For calculations see Materials and Methods.

TransporterInhibitorPTIPCellular Uptake Parameters
Time to Steady StatePSinfaKp w/o Inhibitor: Passive and ActiveKp with Inhibitor: Passive Onlyfu,cellKp,uu
Foldminμl/min per 106 cells
OCT1Ledipasvir>594>180b0.1711551230.008161.27
OATP1B1Venetoclax203>180b0.922662630.00381.01
OATP1B1Cyclosporin A5.881200.923102590.003871.20
OATP1B1Saquinavir3.176010.47294160.002561.75
OAT3Benzbromarone4.96608.293333330.0031.00
OAT1Benzbromarone1.821511.14863960.002531.23
OAT3Valsartan1.4035.5917.81.330.75213.3
OCT2Trimethoprim1.2819.213.34.850.1512.73
  • fu,cell, unbound fraction in the cell; Kp, ratio of steady-state total concentrations measured in the cells versus medium; Kp,uu, ratio of steady-state unbound concentrations in the cells versus medium; PSinf, cellular uptake clearance normalized to cell number.

  • a Time points used for the calculation of the initial slope: ledipasvir: 1–30 min; venetoclax: 1–90 min; cyclosporine A: 15–120 min; saquinavir: 1–5 min; benzbromarone (OAT1 and OAT3): 1–5 min; valsartan: 0 to 1 min; trimethoprim: 0 to 1 min.

  • b Kp values of ledipasvir and venetoclax were calculated with an approximation assuming steady state was reached at 180 min.